National Cheng Kung University Hospital
Tainan, 704, Taiwan
Location status: Recruiting
NCT Number: NCT05856474
The goal of this observational study is to learn about the type of surgical effect on pancreas transection.
The main questions aims to answer are:
* 1. does pancreas preserving able to decrease incidence of postoperative diabeters * 2. what is cause of major cause of postoperative morbidity and mortality in pancreas transection
Interested in participating?
Request Info1 year–70 year
All sexes
Observational
Tainan, 704, Taiwan
Location status: Recruiting
The study design was a retrospective chart review and analysis of Traumatic Pancreas Transection(TPT) patients treated at National Cheng Kung University Hospital. The clinical records, including demographic data, computed tomographic location of pancreas transection with intraoperative confirmation of the pancreatic injury, associated intra-abdominal injuries, interval time between injury and operation, surgical procedure, presence of complication (pancreas and non pancreas related), timing of drain removal, duration of hospital stay and mortality recorded. The secondary end point of morbidity was assessed using the Clavien-Dindo classification.
Initial resuscitation was implemented using ATLS guide-lines. Damage-control laparotomy was applied in critically hemodynamic unstable patients.
In a relatively stable patient, damage control procedure using TAE to control solid organ ongoing hemorrhage and blood transfusion prior to pancreas and associated gastrointestinal surgery. Depending the surgeon preference, TPT patient underwent open or laparoscopic surgery, either using distal pancreatectomy, with or without splenectomy or pancreas preserving pancreatojejunostomy.
Early pancreas surgery is defined as undergoing pancreas reconstructive surgery within 48 hrs. while delayed is considered when beyond 48 hrs. Operative intervention in 42 each patient was individualized based on the surgeon's. Negative suction drain, using Jackson Pratt drain is placed just near proximal pancreas stump.
Drain was removed when the amount was less than 50 cc/day with or without drain amylase/lipase level is less than 3 times of normal serum level.
Morbidity was documented as systemic, intra-abdominal, or specific complications related directly to the pancreatic injury.
Mortality was defined as any cause of death during hospital days. All available postoperative data including blood glucose, Hb1AC, serum and drain amylase lipase level, timing of drain removal, morbidity, hospital stays and mortality was collected and analyzed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
pancreaserving surgery, using end to side or end to end, pancreaticojejunostomy
Other names: pancreaticojejunostomy
Time frame: 6 month
occurence of diabetes following pancreas resection and pancreas preserving surgery
Time frame: 2 week to 4 weeks
pseudocyst and abscess complication following drain removal
Contact information is provided by the study sponsor or research team.
National Cheng-Kung University Hospital
Other
Surgical Management of Traumatic Pancreas Transection
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07430293
Diabetes Mellitus, Endocrine System Diseases
Corbeil-Essonnes, France
View Trial DetailsNCT07532590
Agnosia, Alzheimer Disease
Pavia, Italy
View Trial DetailsNCT06903676
Digestive System Diseases, Pancreatectomy
Indianapolis, Indiana, United States
View Trial DetailsNCT05720338
Cyst of Pancreas, Cysts
Cleveland, Ohio, United States
View Trial Details